* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download SLIDE 4 Live vaccines
Adoptive cell transfer wikipedia , lookup
Social immunity wikipedia , lookup
Globalization and disease wikipedia , lookup
Monoclonal antibody wikipedia , lookup
Sociality and disease transmission wikipedia , lookup
Hygiene hypothesis wikipedia , lookup
Innate immune system wikipedia , lookup
Cancer immunotherapy wikipedia , lookup
Molecular mimicry wikipedia , lookup
Immune system wikipedia , lookup
Polyclonal B cell response wikipedia , lookup
Adaptive immune system wikipedia , lookup
Thiomersal controversy wikipedia , lookup
Psychoneuroimmunology wikipedia , lookup
Whooping cough wikipedia , lookup
Hepatitis B wikipedia , lookup
Childhood immunizations in the United States wikipedia , lookup
Herd immunity wikipedia , lookup
Vaccination policy wikipedia , lookup
Non-specific effect of vaccines wikipedia , lookup
Smallpox vaccine wikipedia , lookup
DNA vaccination wikipedia , lookup
Vaccines SLIDE 1 Edward Jenner discovered the process of vaccination, when he found that injection with cowpox protected against smallpox. His method of immunization via vaccination ushered in the new science of immunology. After observing cases of cowpox and smallpox for a quarter century, Jenner took a step that could have branded him a criminal as easily as a hero. On May 14, 1796, he removed the fluid from a cowpox lesion from dairymaid Sarah Nelmes, and inoculated James Phipps, an eightyear-old boy, who soon came down with cowpox. Six weeks later, he inoculated the boy with smallpox. The boy remained healthy. Jenner had proved his theory. He called his method vaccination, using the Latin word vacca, meaning cow, and vaccinia, meaning cowpox. The publication of Jenner's An Inquiry into the Causes and Effects of the Variolae Vaccinae set off an enthusiastic demand for vaccination throughout Europe. Within 18 months, the number of deaths from smallpox had dropped by two-thirds in England after 12,000 people were vaccinated. By 1800, over 100,000 people had been vaccinated worldwide. As the demand for the vaccine rapidly increased, Jenner discovered that he could take lymph from a smallpox pustule and dry it in a glass tube for use up to three months later. The vaccine could then be transported. SLIDE 2 Passive immunization is used when exposure to pathogen has already occurred and there is not enough time to induce active protective immunity, or prophylactically in children with inherited immune deficiencies or undergoing cancer chemotherapy (which suppresses the immune system). Passive immunization involves administration of specific antibody which has been produced in a human or animal in response to vaccination or environmental exposure to the pathogen. Active immunization Active immunization entails the introduction of a foreign molecule into the body, which causes the body itself to generate immunity against the target. This immunity comes from the T cells and the B cells with their antibodies SLIDE 3 Inactivated vaccines contain particles (usually viruses). These have been grown for the purpose. They have been killed, using formaldehye or by other means (e.g. heat). But the virus still looks intact; the immune system can develop antigens against it. SLIDE 4 Live vaccines - attenuated (weakend) viruses Some vaccines contain live, attenuated microorganisms. Many of these are live viruses that have been cultivated under conditions that disable their virulent properties, or which use closely-related but less dangerous organisms to produce a broad immune response, however some are bacterial in nature. They typically provoke more durable immunological responses and are the preferred type for healthy adults. Examples include the viral diseases yellow fever, measles, rubella, and mumps. SLIDE 5, 6 Recombinant vaccines are those in which genes for desired antigens are inserted into a vector, usually a virus that has a very low virulence. The vector expressing the antigen may be used as the vaccine, or the antigen may be purified and injected as a subunit vaccine. Advantages of recombinant vaccines are that the vector can be chosen to be not only safe but also easy to grow and store, reducing production cost. Antigens which do not elicit protective immunity or which elicit damaging responses can be eliminated from the vaccine, and proteins expressed on a virus, even if it is not the usual pathogen, are more likely to have their native conformation. Disadvantages of recombinant vaccines are their cost to develop, since the genes for the desired antigens must be located, cloned, and expressed efficiently in the new vector. The only recombinant vaccine currently in use in humans is the Hepatitis B Virus (HBV) vaccine, which is a recombinant subunit vaccine. Hepatitis B surface antigen is produced from a gene transfected into yeast cells and purified for injection as a subunit vaccine. This is much safer than using attenuated HBV. BASIC REQUIREMENT page 1 EXTRA REQUIREMENTS SLIDE 7 Subunit vaccines see the slide SLIDE 8 DNA vaccines are the newest vaccines and are still experimental, although to date they seem to be very effective and their safety record is good. Like recombinant vaccines, genes for the desired antigens are located and cloned. In the case of DNA vaccines, however, the DNA is injected into the muscle of the animal being vaccinated, usually with a "gene gun" that uses compressed gas to blow the DNA into the muscle cells. Some muscle cells express the pathogen DNA to stimulate the immune system. Both humoral and cellular immunity have been induced by DNA vaccines. SLIDE 9 Subunit vaccines rather than introducing an inactivated or attenuated microorganism to an immune system (which would constitute a "whole-agent" vaccine), a fragment of it can create an immune response. SLIDE 10 Toxoid vaccines are made from inactivated toxic compounds that cause illness rather than the micro-organism. Examples of toxoid-based vaccines include tetanus and diphtheria. SLIDE 11 Anti-Aids vaccine see the slide. SLIDE 12 Edible vaccines Research into edible vaccines is still at a very early stage and scientists have a long way to go in proving their efficacy. Getting plants to express adequate amounts of the vaccine, is proving challenging enough, let alone translating that into an appropriate immunological response in people. SLIDE 13 Vaccination with mosquitous BASIC REQUIREMENT page 2